This large, prospective registry confirms the very long-term safety and efficacy of the everolimus-eluting stent (EES) in unselected real-world and complex coronary lesions.
Trabattoni D, Fabbiocchi F, Montorsi P, Galli S, Ravagnani P, Calligaris G, Teruzzi G, Grancini L, Troiano S, Ferrari C, Bartorelli AL. A Long-Term Single-Center Registry of 6893 Patients Undergoing Elective Percutaneous Coronary Intervention With the Xience Everolimus-Eluting Stent. J Invasive Cardiol 2019 Jan 15. pii: JIC2019115-3. [Epub ahead of print]